{"nctId":"NCT00089479","briefTitle":"A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer","startDateStruct":{"date":"2002-08"},"conditions":["Breast Cancer"],"count":2611,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: capecitabine [Xeloda]","Drug: Taxotere"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Taxotere"]}],"interventions":[{"name":"capecitabine [Xeloda]","otherNames":[]},{"name":"Taxotere","otherNames":[]},{"name":"Taxotere","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* female patients 18-70 years of age;\n* adenocarcinoma of the breast;\n* previous invasive breast cancer if diagnosed \\>5 years before entering study;\n* no evidence of metastatic disease.\n\nExclusion Criteria:\n\n* history of severe hypersensitivity reaction to Taxotere;\n* previous treatment with anthracycline, anthracenedione (mitoxantrone), or taxane;\n* treatment with fluoropyrimidine (5-fluorouracil) within the last 5 years.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Disease Free Survival [Number of Events]","description":"Number of patients with/without recurrence of breast cancer, or death due to any cause.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"164","spread":null},{"groupId":"OG001","value":"140","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1140","spread":null},{"groupId":"OG001","value":"1167","spread":null}]}]}]},{"type":"SECONDARY","title":"Overall Survival [Number of Events]","description":"Number of patients who died/were alive.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"108","spread":null},{"groupId":"OG001","value":"75","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1196","spread":null},{"groupId":"OG001","value":"1232","spread":null}]}]}]},{"type":"PRIMARY","title":"Disease Free Survival [Time to Event]","description":"Disease free survival was measured as the time from the date of randomization until the date of first event (recurrence of breast cancer, or death due to any cause). Patients without event at the time of the analysis were censored using the date they were last known to be recurrent disease free.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Overall Survival [Time to Event]","description":"Overall survival was measured as the time from the date of randomization to the date of death. Patients still alive at the time of the analysis were censored using the date they were last known to be alive.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Breast Cancer Free Survival [Number of Events]","description":"Number of patients with/without recurrence of breast cancer, new primary breast cancer, or death related to the chemotherapy administered or due to breast cancer.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"144","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1146","spread":null},{"groupId":"OG001","value":"1163","spread":null}]}]}]},{"type":"SECONDARY","title":"Breast Cancer Free Survival [Time to Event]","description":"Breast cancer-free survival was measured as time from the date of randomization to the date of recurrence of breast cancer, new primary breast cancer, or death related to the chemotherapy administered or due to breast cancer. Patients without event at the time of the analysis were censored using the date they were last known to be recurrent disease free.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Disease Free Survival Including New Primary Breast Cancer as Event [Number of Events]","description":"Number of patients with/without recurrence of breast cancer, new primary breast cancer, or death due to any cause.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"169","spread":null},{"groupId":"OG001","value":"154","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1135","spread":null},{"groupId":"OG001","value":"1153","spread":null}]}]}]},{"type":"SECONDARY","title":"Disease Free Survival Including New Primary Breast Cancer as Event [Time to Event","description":"Time from the date of randomization until the date of first event (recurrence of breast cancer, new primary breast cancer, or death due to any cause). Patients without event at the time of the analysis were censored using the date they were last known to be recurrent disease free.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"SECONDARY","title":"Disease Free Survival Including Any New Cancer as Event [Number of Events]","description":"Number of patients with/without recurrence of breast cancer, any new cancer, or death due to any cause.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"200","spread":null},{"groupId":"OG001","value":"177","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1104","spread":null},{"groupId":"OG001","value":"1130","spread":null}]}]}]},{"type":"SECONDARY","title":"Disease Free Survival Including Any New Cancer as Event [Time to Event]","description":"Time from the date of randomization until the date of first event (recurrence of breast cancer, any new cancer, or death due to any cause). Patients without event at the time of the analysis were censored using the date they were last known to be recurrent disease free.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":264,"n":1305},"commonTop":["FATIGUE","NAUSEA","ALOPECIA","NEUTROPENIA","STOMATITIS ALL"]}}}